FIELD: medicine; oncology.
SUBSTANCE: invention relates to the field of medicine, namely to oncology; it is intended for the treatment of tumor diseases of various location. A remedy with antiproliferative and antimetastatic properties is a complex of 3-(2–phenylethyl)-2-thioxo-1,3 thiazolidine-4-one with β-cyclodextrins. Components are used in the claimed amounts.
EFFECT: use of the invention provides for a stable remedy, which, in turn, allows for an increase in the treatment efficiency.
1 cl, 12 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2678769C2 |
USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR NORMALIZATION OF METABOLISM, INCREASE OF NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2768456C2 |
USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
METHOD FOR SIMULATING IMMUNE-DEPENDENT ALLOGENIC PREGNANCY LOSS IN LABORATORY MICE | 2012 |
|
RU2511107C1 |
2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
COMPOSITION OF TRADITIONAL CHINESE MEDICINE, METHOD OF ITS PREPARATION AND ITS USE | 2021 |
|
RU2806632C1 |
DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
Authors
Dates
2021-12-08—Published
2018-06-13—Filed